Navigation Links
Samplify Announces Ultrasound Reference Design
Date:4/26/2010

SAN JOSE, Calif., April 26 /PRNewswire/ -- EMBEDDED SYSTEMS CONFERENCE -- Samplify Systems announced today it is providing ultrasound OEMs with a complete 64-channel ultrasound front-end reference design based on Altera's Cyclone® IV FPGAs and Samplify Systems' SAM1600 ADC and intellectual property (IP).  With low-power, high-performance and continuous-wave Doppler (CWD) processing capabilities, the solution can be used as a common front-end hardware platform for systems ranging from portable, hand-carried ultrasound up to full-featured consoles.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080411/AQF028LOGO )

"Samplify has a proven ultrasound receiver design using their analog front-end SAM1600 ADC," said John Sakamoto, senior director, Application Business Units at Altera.  "This collaboration highlights the combination of Samplify's ADC and Altera's Cyclone IV FPGAs into a development system that allows customers to quickly deliver new products into the marketplace with significant functionality such as 64-channels featuring continuous wave and pulse Doppler modes."

"By providing this complete reference design to OEMs, we can shorten the development time of their analog and digital front-end hardware, and enable them to focus on their core differentiating technologies," said Daniel Kreindler, director of marketing for Medical & Imaging at Samplify Systems. "Altera's Cyclone IV FPGAs are ideal for an ultrasound front-end design based on their low power, high-speed LVDS I/Os required for capturing ADC data at sample rates up to 65 Msample/sec. and support for PCI-Express x4 interface."

This complete front-end design expands upon the success of Samplify's ultrasound receiver AFE (Analog Front End) reference design by adding a complete transmit path and including Cyclone IV FPGAs for the Receive and Transmit beamforming functions. The design provides 100 mW per receive channel, the industry's lowest power consumption, while delivering up to 6 dB higher dynamic range than competing AFE solutions.  Cyclone IV FPGAs have a wide range of device densities in various package options that allow OEMs to customize this reference design according to their cost/performance trade-offs. The new 64-channel reference design features CWD processing for 32 analog input channels and a single Cyclone IV GX FPGA to implement a PCI-Express x4 host interface plus three Cyclone IV E FPGAs to support beamforming implementation, making it a complete Rx/Tx ultrasound front end design with an interface to the back-end computer.

Pricing and Availability:

The reference design will be available in the third quarter of 2010.  Samplify can provide full schematics, Gerber files, as well as Verilog RTL components at no charge to SAM1600 and Cyclone IV customers. Email sales@samplify.com for complete information.  Samplify is exhibiting at the Embedded Systems Conference, Silicon Valley, Booth 3028, from April 26-29th at the McEnery Convention Center in San Jose, CA.

About Samplify

Samplify is a venture-funded solution provider of signal compression technology and semiconductor products. Headquartered in Santa Clara, CA, Samplify's customers include medical imaging and wireless infrastructure companies. Samplify's technology and semiconductor products, including the SAM1600 family, have won multiple industry awards for innovation, including the first data converter with integrated data compression. Additional information about Samplify can be found at www.samplify.com.

Prism is a trademark and simply the bits that matter is a registered trademark of Samplify Systems.


'/>"/>
SOURCE Samplify Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Samplify Systems Next-Generation Prism 3.0 Real-Time Compression IP Named Finalist in EDN Magazines 20th Annual Innovation Awards
2. PolyTouch Medical Ltd. Announces the Appointment of Karl A. LeBlanc, MD, MBA, FACS as Medical Advisor
3. Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast
4. pHase Pharmaceuticals Announces New Venture
5. Sagent Pharmaceuticals Announces U.S. FDA Tentative Approval of Additional Adenosine Injection, USP Vial Presentations
6. Dehaier Medical Systems Announces Closing of Initial Public Offering on NASDAQ
7. Renhuang Pharmaceuticals Announces Continual Improvement in Days Sales Outstanding
8. Codexis, Inc. Announces Pricing of Initial Public Offering
9. Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors
10. Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
11. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... Israel , May 4, 2016 ... today that BiondVax,s CEO, Dr. Ron Babecoff , will ... New York City . On Thursday, ... Pioneers 2016, a conference presented by Joseph Gunner ... The BiondVax presentation that Dr. Babecoff will be ...
(Date:5/4/2016)... -- Yissum Research Development Company of ... it had signed an exclusive world-wide licensing and research ... protein degradation and immunomodulatory drugs for cancer and immune ... representing first-in-class therapy for hematologic and solid malignancies. Financial ... The novel technology was developed by Yinon Ben-Neriah ...
(Date:5/4/2016)... Valeritas Holdings, Inc. (OTCQB: VLRX) ... offering (APO). This was accomplished via a reverse merger ... a private placement of approximately 5 million shares of ... Under the terms of the reverse merger, which ... will trade on the OTC Markets under the symbol ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... May 06, 2016 , ... In honor of Military ... corporate training, and the National Military Family Association, a nonprofit that works to ... second full-tuition scholarship recipient of 2016. , “Being awarded this scholarship by ...
(Date:5/6/2016)... ... , ... “ Crossing Over: Affirmations of Faith in the Midst of the ... those holding vigil to glimpse into the supernatural as their lives ended. With her ... and practically gain insight into providing care to terminal patients. , “I was ...
(Date:5/5/2016)... Tucson, AZ (PRWEB) , ... May 05, 2016 , ... ... more attention being paid to the impact our aging population has on communities and ... help aging adults plan for and face age-related challenges. , Aging Life Care ...
(Date:5/5/2016)... ... 05, 2016 , ... Textile Exchange is excited to announce the ... review. The stakeholder review is an important opportunity for interested parties to give input ... to the wool industry., The RWS is intended to be a global benchmark for ...
(Date:5/5/2016)... ... 05, 2016 , ... Florida Hospital Pepin Heart Institute was ... an alternative to long-term warfarin medication with the newly approved WATCHMAN Left Atrial ... Florida Hospital Pepin Heart Institute doctors successfully implanted the Watchman device in four ...
Breaking Medicine News(10 mins):